Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guerin-Naive High-Risk Nonmuscle-Invasive Bladder Cancer. McElree IM, Steinberg RL, Martin AC, Richards J, et al. J Urol 2022 Jul 27:101097JU0000000000002740. doi: 10.1097/JU.0000000000002740.

Read + Share

Amedeo Smart

Independent Medical Education

McElree IM, Steinberg RL, Martin AC, Richards J, et al. Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guerin-Naive High-Risk Nonmuscle-Invasive Bladder Cancer. J Urol 2022 Jul 27:101097JU0000000000002740. doi: 10.1097/JU.0000000000002740.
PMID: 35892270